Is this the perfect storm of corruption? ACNP Journal Review VNS
Operating like thieves under the cover of darkness, prominent academic-based "authorities" in medical specialties have debased academic standards and sold their reputations for cash-
Operating like thieves under the cover of darkness, prominent academic-based "authorities" in medical specialties have debased academic standards and sold their reputations for cash-
The latest investigative report focusing on financial conflicts of interest by Pulitzer Prize winner, David Willman of the Los Angeles Times, reveals that even as the NIH director, Dr. Elias Zerhouni, announced publicly last year that scientists at the National Institutes of Health would be barred from accepting consulting fees from industry, evidence shows that the ban is clearly not being enforced.
A front page article in The New York Times reports: "The breakfast buffet at Camp Echo starts at a picnic table covered in gingham-patterned oil cloth.
Following on the heels of an investigative report by David Armstrong of The Wall Street Journal <https://ahrp.org/cms/content/view/286/27/> the Associated Press reports that JAMA claims it was misled.
Three essays provide an overview of the bias that has debased the integrity of medical research literature while increasing the hazards of medical practice–for patients and doctors who are kept in the dark about prescribed treatment dangers.
Two probing first rate investigative reports document how psychiatry’s treatments are shaped by "opinion leaders" whose professional recommendations are compromised by their substantial, largely undisclosed, financial ties to drug companies.
An investigative report in Mercury News (below) focuses on Stanford University department heads, associate deans and other leaders because “these are senior people who set the tone at the medical school and are role models for junior faculty members.”
Dr. David Healy, a formidable critic of the iron grip pharmaceutical corporations wield on the practice of psychiatry as well as on psychiatry’s deficient journal reports, directs his criticism at drug regulators in an article in the current British Medical Journal (BMJ).
"Drug companies should not be allowed to evaluate their own products."
Yesterday we forwarded an article about Tylenol-linked liver damage published by Associated Press. https://ahrp.org/cms/content/view/278/28/
Below two recent reports by Counterpunch.
Agence France Presse reports that suicide rates in Russia have decreased. Not surprisingly the highest suicide rate in Russia is in Siberia.
Overreliance on toxic drugs is killing healthy people. And the FDA has done next to nothing to prevent drug-induced harm.